IDEXX Laboratories has a total of 1278 patents globally, out of which 688 have been granted. Of these 1278 patents, more than 55% patents are active. United States of America is where IDEXX Laboratories has filed the maximum number of patents, followed by Europe and Japan. Parallelly, USA seems to be the main focused R&D center and is also the origin country of IDEXX Laboratories.
IDEXX Laboratories was founded in 1983 by David Evans Shaw. IDEXX Laboratories provides diagnostic, detection, and information systems for veterinary, food, and water testing applications. The Company also operates an international network of veterinary reference laboratories. IDEXX offers its products to customers worldwide. As of April 2022, IDEXX Laboratories has a market cap of $46.42 Billion.
Do read about some of the most popular patents of IDEXX Laboratories which have been covered by us in this article and also you can find IDEXX Laboratories patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over IDEXX Laboratories patent portfolio.
How many patents does the Founder and CEO of IDEXX Laboratories have?
The Founder David Evans Shaw has 0 patents and the CEO, Jay Mazelsky has 0 patents.
How many patents does IDEXX Laboratories have?
IDEXX Laboratories has a total of 1278 patents globally. These patents belong to 262 unique patent families. Out of 1278 patents, 709 patents are active.
How Many Patents did IDEXX Laboratories File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||IDEXX Laboratories Applications Filed||IDEXX Laboratories Patents Granted|
How many IDEXX Laboratories patents are Alive/Dead?
How Many Patents did IDEXX Laboratories File in Different Countries?
Countries in which IDEXX Laboratories Filed Patents
|United States Of America||295|
|Hong Kong (S.A.R.)||7|
Where are the Research Centers of IDEXX Laboratories Patents Located?
10 Best IDEXX Laboratories Patents
US6511814B1 is the most popular patent in the IDEXX Laboratories portfolio. It has received 141 citations so far from companies like Philip Morris, Pronota Nv and Kimberly-Clark Worldwide Inc.
Below is the list of 10 most cited patents of IDEXX Laboratories:
|Publication Number||Citation Count|
Which Companies are using IDEXX Laboratories Patents to Advance their Research?
If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.
The top citing companies in the IDEXX Laboratories patent portfolio are Sysmex Corporation, Aratana Therapeutics Inc and Fujifilm.
List of the top forward citing Companies –
|Company||Number of Patents|
|Aratana Therapeutics Inc||5|
|Bruker Daltonik Gmbh||4|
|Medical Diagnostic Laboratories Llc||3|
|Siemens Healthcare Gmbh||2|
|Ohio State Innovation Foundation||2|
|Roche Diagnostics Hematology Inc||2|
Count of 102 and 103 Type Rejections based on IDEXX Laboratories Patents
Top IDEXX Laboratories Patents used in Rejecting Most Patent Applications
|Patent Number||Count of Rejected Applications|
What Percentage of IDEXX Laboratories US Patent Applications were Granted?
IDEXX Laboratories (Excluding its subsidiaries) has filed 266 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 183 have been granted leading to a grant rate of 80.26%.
Below are the key stats of IDEXX Laboratories’ patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for IDEXX Laboratories?
|Law Firm||Total Applications||Success Rate|
|Mcdonnell Boehnen Hulbert & Berghoff Llp||123||82.57%|
|Carter Deluca & Farrell Llp||24||66.67%|
|Gerald T Bodner||18||100.00%|
|Dla Piper Llp||17||100.00%|
|Parker Poe Adams & Bernstein Llp||13||100.00%|
|Dentons Us Llp||8||87.50%|
|Richard J Rodrick||8||100.00%|
|Haynes And Boone Llp||7||28.57%|
|Chris A Caseiro||4||0%|
EXCLUSIVE INSIGHTS COMING SOON!
What are IDEXX Laboratories’ key innovation segments?